Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

Sponsored by ModernaTX, Inc.Study detailsClinicalTrials.gov

5 US sites in GA, LA, MS, OK

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.